Attys Seek $113M In Fees From Glumetza Buyers' $454M Deal
By Dave Simpson · December 2, 2021, 6:52 PM EST
A class of direct Glumetza buyers who scored $454 million in settlements that will end several claims that drugmakers plotted to delay the generic version of the blockbuster diabetes drug asked...
To view the full article, register now.